CTLA4 and neoplasm: The administration of antibiotics had a considerable negative impact on the efficacy of anti-PD-1 monoclonal antibody therapy, either alone or in combination with anti-CTLA-4 antibodies, resulting in increased tumor size, reduced antitumor effects and decreased survival in germ-free mice [3].